Stellate Ganglion Block
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18-85
SponsorUniversity of Minnesota
About this trial
The purpose of this study is to determine if the addition of an ultrasound guided left sided stellate ganglion block with bupivacaine in patients undergoing esophagectomy, pneumonectomy, or lobectomy will result in lower rates of postoperative atrial fibrillation as compared to standard of care.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients undergoing esophagectomy, pneumonectomy, or lobectomy aged 18-85.
Disqualifiers
Patients who have an exclusion to regional anesthesia.
Patients who have exclusion to stellate blockade.
Patients who are pregnant assessed via self-report or pregnancy test if they have taken one
Trial design
Design model
Parallel
Treatments tested in this trial
0.5% bupivacaine
Drugan ultrasound guided left stellate ganglion block with 5 mL of 0.5% bupivacaine
Saline
Other interventionan ultrasound guided left stellate ganglion block with 5 mL of saline
Treatment groups
48 Participants
are divided into 2 treatment groupsGroup A: Group 1Experimental treatment 1 intervention
Group B: Group 2Sham comparator 1 intervention
Trial outcomes
Primary outcomes
1
an ultrasound guided left stellate ganglion block with 5 mL of saline.
Incidence of Atrial fibrillation in the first 168 hours after surgery.
Time frame
168 hours after surgery2
Atrial fibrillation; Other arrhythmias; Adverse events.
Atrial fibrillation in first 24, 48, 72, 96, 120, and 144 hours; Other arrhythmias in first 24, 48, 72, 96, 120, 144 and 168 hours; Adverse events.
Time frame
168 hours after surgerySponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov